Literature DB >> 30741786

Understanding the schizophrenia phenotype in the first patient with the full SCN2A phenotypic spectrum.

Jessica S Suddaby1, Josh Silver1,2, Joyce So1,3,4.   

Abstract

The sodium voltage-gated channel α subunit 2 (SCN2A) gene encodes a subunit of sodium voltage-gated channels expressed primarily in the central nervous system that are responsible for action potential initiation and propagation in excitable cells. SCN2A mutations underlie a spectrum of distinct phenotypes, including seizure disorders, neurodevelopmental disorders, and rarer instances of episodic ataxia and schizophrenia. We report on a 38-year-old patient with adult-onset psychotic symptoms on a background of infantile-onset seizures, autistic features and episodic ataxia. Whole-exome sequencing revealed a de-novo novel SCN2A mutation (c.4966T > C, p.Ser1656Pro). This and other SCN2A mutations associated with the schizophrenia phenotype overlap those seen in neurodevelopmental disorders, suggesting a common underlying mechanism. This is the first report of a patient with the entire known SCN2A phenotypic spectrum. We highlight the importance of recognizing the psychiatric phenotypes associated with SCN2A mutations and that the phenotypic spectrum is more fluid, and less categorical, than previously thought.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30741786     DOI: 10.1097/YPG.0000000000000219

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN: 0955-8829            Impact factor:   2.458


  3 in total

1.  Assessment of Potential Clinical Role for Exome Sequencing in Schizophrenia.

Authors:  Thivia Balakrishna; David Curtis
Journal:  Schizophr Bull       Date:  2020-02-26       Impact factor: 9.306

2.  SCN2A-Related Epilepsy: The Phenotypic Spectrum, Treatment and Prognosis.

Authors:  Qi Zeng; Ying Yang; Jing Duan; Xueyang Niu; Yi Chen; Dan Wang; Jing Zhang; Jiaoyang Chen; Xiaoling Yang; Jinliang Li; Zhixian Yang; Yuwu Jiang; Jianxiang Liao; Yuehua Zhang
Journal:  Front Mol Neurosci       Date:  2022-03-30       Impact factor: 5.639

3.  Epilepsy Benchmarks Area IV: Limit or Prevent Adverse Consequence of Seizures and Their Treatment Across the Life Span.

Authors:  Jana E Jones; Miya R Asato; Mesha-Gay Brown; Julia L Doss; Elizabeth A Felton; Jennifer A Kearney; Delia Talos; Penny A Dacks; Vicky Whittemore; Annapurna Poduri
Journal:  Epilepsy Curr       Date:  2020-01-23       Impact factor: 7.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.